Found: 20
Select item for more details and to access through your institution.
Hybrid simultaneous whole-body 2-[<sup>18</sup>F]FDG-PET/MRI imaging in newly diagnosed multiple myeloma: first diagnostic performance and clinical added value results.
- Published in:
- European Radiology, 2023, v. 33, n. 9, p. 6438, doi. 10.1007/s00330-023-09593-1
- By:
- Publication type:
- Article
Semi-Quantitative [ 18 F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell Arteritis.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15528, doi. 10.3390/ijms232415528
- By:
- Publication type:
- Article
Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5406, doi. 10.3390/ijms21155406
- By:
- Publication type:
- Article
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 445, doi. 10.3390/ijms18020445
- By:
- Publication type:
- Article
New Developments in Myeloma Treatment and Response Assessment.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1331, doi. 10.2967/jnumed.122.264972
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 257, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Multiple myeloma mimicking metastatic skull base paraganglioma in [<sup>68</sup> Ga]Ga-DOTATOC-PET/CT and 2-[<sup>18</sup>F]FDG-PET/CT imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 12, p. 3792, doi. 10.1007/s00259-023-06322-0
- By:
- Publication type:
- Article
RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutation.
- Published in:
- EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.8
- By:
- Publication type:
- Article
Specific features to differentiate Giant cell arteritis aortitis from aortic atheroma using FDG-PET/CT.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-96923-2
- By:
- Publication type:
- Article
Leveraging RSF and PET images for prognosis of multiple myeloma at diagnosis.
- Published in:
- International Journal of Computer Assisted Radiology & Surgery, 2020, v. 15, n. 1, p. 129, doi. 10.1007/s11548-019-02015-y
- By:
- Publication type:
- Article
Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 4, p. 1005, doi. 10.1007/s00259-020-05049-6
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in multiple myeloma: critical insights and future directions.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2532, doi. 10.3390/cancers12092532
- By:
- Publication type:
- Article
FDG-PET/CT, a Promising Exam for Detecting High-Risk Myeloma Patients?
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1384, doi. 10.3390/cancers12061384
- By:
- Publication type:
- Article
Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple Myeloma.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 486, doi. 10.3390/cancers12020486
- By:
- Publication type:
- Article